Philadelphia Zantac Lawsuit Information | Zantac Cancer Claims for Philadelphia Residents

Information for Residents of Philadelphia from Heartburn Drug Cancer Attorneys

Philadelphia Zantac Lawsuits

If you or a loved one in Philadelphia developed Liver, Bladder, Colorectal, Prostate, Esophageal/Throat/Nasal, Stomach, Brain, Kidney (Renal), Pancreatic, Lung, Testicular, Breast, Non-Hodgkin Lymphoma, Mouth, Small Intestine, Large Intestine, Anal, Gallbladder, Appendix or Cecum cancer after taking medication for acid reflux or heartburn, you may be eligible to file an antacid cancer lawsuit in Philadelphia. This page contains information about who can file antacid cancer lawsuits in Philadelphia and heartburn drug cancer lawsuit time limits.

Philadelphia Zantac Cancer Lawsuit FAQs

This page contains answers to common questions regarding Zantac and other antacid cancer lawsuits in Philadelphia, including a list of drugs subject to recall and information on legal fees. This information has been compiled by our attorneys handling antacid cancer lawsuits in Philadelphia.

Antacid Cancer Lawsuit Information for Philadelphia Residents

Residents of Philadelphia are becoming incresingly aware that heartburn and acid reflux medicines such as Prilosec, Zantac, Prevacid, Nexium and generic Zantac have been found to cause cancer. Available by prescription and over-the-counter in Philadelphia and nationwide, antacids are used daily by millions of Americans. Cancer from heartburn medicines is the subject of ongoing FDA investigation, and many of these products are now subject to acid reflux drug recalls or have been pulled off the shelf in major Philadelphia drug stores including CVS, Walgreens, Walmart and Rite Aid. Countless people have unknowingly been subjected to a risk for antacid cancer in Philadelphia at no fault of their own.

Among the most popular drugs in the world, Prilosec, Zantac, ranitidine or generic Zantac, Nexium and Prevacid have yielded billions in revenue for multinational pharmaceutical corporations including Astra-Zeneca, Takeda Pharmaceuticals, Procter & Gamble, Sanofi / Boerhringer Ingelheim, Sandoz / Novartis, and others. Pharmaceutical companies are responsible for conducting long-term safety studies and warning the public in Philadelphia and beyond of drug side effects. In the case of Zantac, ranitidine, Prilosec, Prevacid and Nexium, manufacturers failed to warn federal regulators or Philadelphia consumers of the antacid cancer risk.

Now drugmakers face serious questions regarding their knowledge of the link between cancer and acid reflux medicine. Persons and the family members of persons in Philadelphia who were diagnosed with stomach cancer, bladder cancer, or another similar type of cancer after taking these medications are filing heartburn medicine cancer lawsuits in Philadelphia against the manufacturers. Filing an antacid lawsuit is the only means for a Philadelphia resident to obtain compensation for suffering, damage, medical expenses and loss related to cancer caused by acid reflux medicine in Philadelphia. In addition, filing a heartburn medicine lawsuit claim in Philadelphia is the best method for Philadelphia consumers to hold multinational pharmaceutical giants accountable for widespread unethical business practices.